Efficacy of Switching from Infliximab to Subcutaneous Golimumab in Patients with Rheumatoid Arthritis to Control Disease Activity or Adverse Events. - Wakabayashi, Hiroki; Inada, Hitoshi; Nishioka, Yosuke; Hasegawa, Masahiro; Nishioka, Kusuki; Sudo, Akihiro (Drugs in R&D, 2017)